← Leaderboards
Georgette D. Kanmogne
University Of Oklahoma Hlth Sciences Ctr
$8,623,744
Attributed
$8,623,744
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,623,744 · 7
By mechanism
R01$6,630,787 · 3
R21$788,688 · 2
P01$687,139 · 1
K01$517,130 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- David Sparling$375,702
- Heather C. Rice$2,698,630
- Adam Zlotnick$11,682,701
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionHiv-1Blood - Brain Barrier AnatomyHiv InfectionsIn VitroInjuryTight JunctionsMacrophagePlayAffectImpairmentCellsInterleukin-6Functional DisorderPathway InteractionsBrainInflammatoryPreventAids Dementia ComplexAnimal ModelNeuronsAids/Hiv ProblemDesignIn Vivo
Grant awards (26)
PREVENTING ALZHEIMERâS DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5$690,748
R01 · FY2025 · MH · contact PI
PREVENTING ALZHEIMERâS DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5$690,748
R01 · FY2024 · MH · contact PI
PREVENTING ALZHEIMERâS DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5$690,748
R01 · FY2023 · MH · contact PI
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5$229,750
R21 · FY2022 · MH · contact PI
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5$191,250
R21 · FY2021 · MH · contact PI
HIV Genetic Diversity and Viral Neuropathogenesis$540,444
R01 · FY2016 · MH · contact PI
HIV Genetic Diversity and Viral Neuropathogenesis$537,891
R01 · FY2015 · MH · contact PI
HIV Genetic Diversity and Viral Neuropathogenesis$679,710
R01 · FY2014 · MH · contact PI
HIV Genetic Diversity and Viral Neuropathogenesis$639,818
R01 · FY2013 · MH · contact PI
HIV Genetic Diversity and Viral Neuropathogenesis$696,560
R01 · FY2012 · MH · contact PI
Blood brain barrier immune compromise in NeuroAIDS$291,060
R01 · FY2012 · MH · contact PI
Macrophage, blood-brain barrier, and modulation of neurodegeneration$226,292
P01 · FY2012 · NS · contact PI
Blood brain barrier immune compromise in NeuroAIDS$291,060
R01 · FY2011 · MH · contact PI
Macrophage, blood-brain barrier, and modulation of neurodegeneration$227,997
P01 · FY2011 · NS · contact PI
Blood brain barrier immune compromise in NeuroAIDS$294,000
R01 · FY2010 · MH · contact PI
Macrophage, blood-brain barrier, and modulation of neurodegeneration$232,850
P01 · FY2010 · NS · contact PI
Blood brain barrier immune compromise in NeuroAIDS$294,000
R01 · FY2009 · MH · contact PI
Blood brain barrier immune compromise in NeuroAIDS$294,000
R01 · FY2008 · MH · contact PI
NeuroAIDS in Cameroon: Molecular determinants$195,487
R21 · FY2008 · MH · contact PI
NeuroAIDS in Cameroon: Molecular determinants$172,201
R21 · FY2007 · MH · contact PI
HIV-1 gp120-induced Endothelial Cell Dysfunction$106,390
K01 · FY2007 · MH · contact PI
HIV-1 gp120-induced Endothelial Cell Dysfunction$104,865
K01 · FY2006 · MH · contact PI
HIV-1 gp120-induced Endothelial Cell Dysfunction$103,383
K01 · FY2005 · MH
HIV-1 gp120-induced Endothelial Cell Dysfunction$55,397
K01 · FY2004 · MH
HIV-1 gp120-induced Endothelial Cell Dysfunction$46,547
K01 · FY2004 · MH
HIV-1 gp120-induced Endothelial Cell Dysfunction$100,548
K01 · FY2003 · MH